Ctf Capital Management, LP Verona Pharma PLC Call Options Transaction History
Ctf Capital Management, LP
- $135 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
208Shares Held
73.3MCall Options Held
1.53MPut Options Held
702K-
Perceptive Advisors LLC New York, NY6.39MShares$394 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$344 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$209 Million5.24% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$193 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$193 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.76B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...